News

Video

ASCRS 2025: Eva Kim, MD, says patient comfort is paramount when using implantable collamer lenses

Author(s):

For patients with high myopia, an implantable ICL offers certain advantages over LASIK or other traditional refractive surgeries, Dr. Kim said.

This year, the American Society of Cataract and Refractive Surgery (ASCRS) holds its annual meeting in Los Angeles, California. On the first day of the meeting, the Eye Care Network spoke with Eva Kim, MD, an ophthalmologist and refractive specialist from Denver, Colorado. She spoke about the EVO implantable collamer lens (ICL), a reversible intervention for patients with high myopia. According to Dr. Kim, these ICLs have a number of qualities which make them appealing to younger patients with high myopia, including removability and a less-invasive implantation procedure. There's also no need for a preoperative laser peripheral iridotomy—a factor which wins over many patients, she said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
(Image credit: Ophthalmology Times) Oluwatosin U. Smith talks Glaukomtecken
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
© 2025 MJH Life Sciences

All rights reserved.